Commitments and Contingencies (Details)			1 Months Ended				3 Months Ended		12 Months Ended
	Jul. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Mar. 31, 2025 USD ($) shareholder	Apr. 30, 2023 USD ($)	Sep. 30, 2011 USD ($)	Jun. 30, 2011 USD ($)	Mar. 31, 2025 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Other Commitments [Line Items]
Advances on inventory purchases			$ 18,200,000				$ 18,200,000
Obligation subject to milestone achievement			25,700,000				25,700,000
Take-Or-Pay basis, term				5 years
Take-Or-Pay basis, contract cost				$ 33,000,000
Purchase obligation				5,000,000
Purchase obligation, minimum, amount				$ 7,000,000
Advance payment									$ 16,600,000
Impairment of long lived assets							16,600,000
Other liabilities, current			$ 410,000				410,000		$ 2,754,000
License payment, royalty payment							0
Number of plaintiffs (in shareholders) | shareholder			2
Origin 1
Other Commitments [Line Items]
Impairment of long-lived assets additonal settlements							400,000
Nonexclusive Patents Llicense Agreement
Other Commitments [Line Items]
License agreement amount											$ 5,000,000
Additional payments for license agreement										$ 7,900,000
Percentage of net sales						0.40%
Nonexclusive Patents License Agreement
Other Commitments [Line Items]
License agreement amount							12,900,000
Patent License Agreement
Other Commitments [Line Items]
License agreement amount	$ 100,000	$ 500,000
Royalty payment per year						$ 100,000
Royalty payment, cumulative amount		500,000			$ 10,000,000.0
Upfront license fee royalty and a variable royalty, aggregate cap per facility		$ 10,000,000
License payment, royalty payment							$ 100,000	$ 0
Patent License Agreement | Minimum
Other Commitments [Line Items]
Royalty payment per year	$ 100,000
Patent License Agreement | Maximum
Other Commitments [Line Items]
Royalty payment, cumulative amount					$ 2,000,000.0